Literature DB >> 32454740

Synthesis and Hypoglycemic and Anti-inflammatory Activity Screening of Novel Substituted 5-[Morpholino(Phenyl)Methyl]-Thiazolidine-2,4-Diones and Their Molecular Docking Studies.

Srikanth Kumar Karumanchi1, Lakshmana Rao Atmakuri1, V Basaveswara Rao Mandava2, Srikala Rajala3.   

Abstract

OBJECTIVES: The aim was the synthesis of novel substituted 5-[morpholino(phenyl)methyl]-thiazolidine-2,4-diones and screening for their in vivo hypoglycemic activity and in vitro anti-inflammatory activity, as well as molecular docking studies to find out active potential lead molecules.
MATERIALS AND METHODS: Substituted aromatic aldehydes, thiazolidine-2,4-dione, and morpholine on Mannich reaction gave the title compounds. They were characterized by physical and spectral methods. In vivo hypoglycemic activity was examined in alloxan induced Wistar albino rats by tail tipping method. In vitro anti-inflammatory activity was tested by human red blood cell (HRBC) membrane stabilization and protein denaturation. Using AutoDock, molecular docking studies were carried out to find out the best fit ligands.
RESULTS: Series of substituted 5-[morpholino(phenyl)methyl]-thiazolidine-2,4-diones were synthesized and chemically they were confirmed by spectral techniques. Acute toxic studies of in vivo hypoglycemic activity results revealed that compounds 4c, 4h, and 4n exhibited good activity at 35 mg/kg body weight. Chronic toxic study results indicated that compounds 4h and 4n exhibited good activity at 70 mg/kg body weight. Anti-inflammatory activity results indicated the highest inhibition was shown by compounds 4k and 4f at 500 μg/mL in HRBC membrane stabilization. In protein denaturation, the highest inhibition was shown by compound 4k at 500 μg/mL. In molecular docking studies, compounds 4h and 4n exhibited higher binding affinity at PPARγ receptor protein and compound 4k exhibited higher binding affinity at COX-1 and COX-2 actives sites.
CONCLUSION: Microwave irradiation produced high yield in short reaction times. The presence of electron releasing groups at the para position of the phenyl ring may give the ability to produce hypoglycemic activity and the presence of electron withdrawing groups at the para position of the phenyl ring causes anti-inflammatory activity. The results showed that some compounds exhibited good hypoglycemic and anti-inflammatory activities. Compounds 4h and 4n exhibited higher binding affinity at PPARγ receptor protein and compound 4k exhibited higher binding affinity at COX isoenzymes' active sites in molecular docking studies. ©Copyright 2019 Turk J Pharm Sci, Published by Galenos Publishing House.

Entities:  

Keywords:  Mannich reaction; Thiazolidinediones bearing morpholine; docking studies; in vitro anti-inflammatory activity; in vivo hypoglycemic activity

Year:  2019        PMID: 32454740      PMCID: PMC7227886          DOI: 10.4274/tjps.galenos.2018.82612

Source DB:  PubMed          Journal:  Turk J Pharm Sci        ISSN: 1304-530X


  16 in total

1.  Synthesis, glucose uptake activity and structure-activity relationships of some novel glitazones incorporated with glycine, aromatic and alicyclic amine moieties via two carbon acyl linker.

Authors:  B R Prashantha Kumar; Mukesh Soni; S Santhosh Kumar; Kuldeep Singh; Mohan Patil; R B Nasir Baig; Laxmi Adhikary
Journal:  Eur J Med Chem       Date:  2010-12-23       Impact factor: 6.514

2.  Structure-activity requirements for the antiproliferative effect of troglitazone derivatives mediated by depletion of intracellular calcium.

Authors:  Yun-Hua Fan; Han Chen; Amarnath Natarajan; Yuhong Guo; Fred Harbinski; Julia Iyasere; William Christ; Huseyin Aktas; Jose A Halperin
Journal:  Bioorg Med Chem Lett       Date:  2004-05-17       Impact factor: 2.823

Review 3.  The impact of microwave-assisted organic synthesis in drug discovery.

Authors:  Farah Mavandadi; Ake Pilotti
Journal:  Drug Discov Today       Date:  2006-02       Impact factor: 7.851

4.  Synthesis and biological evaluation of novel pyrazolyl-2,4-thiazolidinediones as anti-inflammatory and neuroprotective agents.

Authors:  Amal M Youssef; M Sydney White; Erika B Villanueva; Ibrahim M El-Ashmawy; Andis Klegeris
Journal:  Bioorg Med Chem       Date:  2010-01-15       Impact factor: 3.641

5.  Synthesis and SAR of thiazolidinedione derivatives as 15-PGDH inhibitors.

Authors:  Ying Wu; Hsin-Hsiung Tai; Hoon Cho
Journal:  Bioorg Med Chem       Date:  2010-01-11       Impact factor: 3.641

6.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

Authors:  Sarah Wild; Gojka Roglic; Anders Green; Richard Sicree; Hilary King
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

7.  Synthesis, induced-fit docking investigations, and in vitro aldose reductase inhibitory activity of non-carboxylic acid containing 2,4-thiazolidinedione derivatives.

Authors:  Rosanna Maccari; Rosaria Ottanà; Rosella Ciurleo; Dietmar Rakowitz; Barbara Matuszczak; Christian Laggner; Thierry Langer
Journal:  Bioorg Med Chem       Date:  2008-05-03       Impact factor: 3.641

8.  Evaluation of in vitro aldose redutase inhibitory activity of 5-arylidene-2,4-thiazolidinediones.

Authors:  Rosanna Maccari; Rosaria Ottanà; Rosella Ciurleo; Maria Gabriella Vigorita; Dietmar Rakowitz; Theodora Steindl; Thierry Langer
Journal:  Bioorg Med Chem Lett       Date:  2007-05-06       Impact factor: 2.823

9.  Synthesis and antitumor activity of substituted triazolo[4,3-a]pyrimidin-6-sulfonamide with an incorporated thiazolidinone moiety.

Authors:  Hend N Hafez; Abdel-Rahman B A El-Gazzar
Journal:  Bioorg Med Chem Lett       Date:  2009-06-06       Impact factor: 2.823

10.  Conventional and microwave assisted synthesis of pyrazolone Mannich bases possessing anti-inflammatory, analgesic, ulcerogenic effect and antimicrobial properties.

Authors:  Kullampalayam Krishnasamy Sivakumar; Aiyalu Rajasekaran; Palaniappan Senthilkumar; Prasad P Wattamwar
Journal:  Bioorg Med Chem Lett       Date:  2014-04-28       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.